Nalaganje...
Obesity medications in development
INTRODUCTION: Obesity is compounded by a neurobiology that is resistant to weight loss. Therefore, the development of pharmacotherapies to address the pathology underlying the dysregulation of energy homeostasis is critical. AREAS COVERED: This review examines selected clinical trial evidence for th...
Shranjeno v:
| izdano v: | Expert Opin Investig Drugs |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6990416/ https://ncbi.nlm.nih.gov/pubmed/31847611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543784.2020.1705277 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|